Updated Jul 16, 2026
GOLDSTEIN DOV A MD has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $532K.
Dov A. Goldstein, MD, is a corporate director involved with Gain Therapeutics, Inc. and Coya Therapeutics, Inc. He has experience in the biotechnology sector, particularly in developing therapies for various diseases.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-24 | BIOA | BioAge Labs, Inc. | M — Option exercise | 3.5K | $4.38 | $16K |
| 2026-03-03 | BIOA | BioAge Labs, Inc. | M — Option exercise | 3.5K | $4.38 | $16K |
| 2026-02-03 | BIOA | BioAge Labs, Inc. | M — Option exercise | 3.5K | $4.38 | $16K |
| 2026-01-21 | BIOA | BioAge Labs, Inc. | M — Option exercise | 3.5K | $4.38 | $16K |
| 2026-01-15 | BIOA | BioAge Labs, Inc. | S — Open-market sale [10b5-1] | 1.9K | $21.08 | $41K |
| 2026-01-15 | BIOA | BioAge Labs, Inc. | S — Open-market sale [10b5-1] | 11.7K | $20.54 | $240K |
| 2026-01-15 | BIOA | BioAge Labs, Inc. | S — Open-market sale [10b5-1] | 4.4K | $19.45 | $86K |
| 2026-01-15 | BIOA | BioAge Labs, Inc. | S — Open-market sale [10b5-1] | 9.0K | $18.43 | $165K |
| 2026-01-15 | BIOA | BioAge Labs, Inc. | M — Option exercise [10b5-1] | 27.0K | $8.39 | $227K |
| 2025-08-18 | COYA | Coya Therapeutics, Inc. | M — Option exercise | 17.6K | $1.09 | $19K |
Dov A. Goldstein, MD, is a corporate director involved with Gain Therapeutics, Inc. and Coya Therapeutics, Inc. He has experience in the biotechnology sector, particularly in developing therapies for various diseases.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($532K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GOLDSTEIN DOV A MD profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.